From a molecular clinical viewpoint, Relafen 750 ( Naproxen Sodium ) presents a interesting case. Its mechanism of function primarily involves inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing prostaglandin production . This leads to decreased pain and fever . The compound's relatively long persistence and specifi